TD Cowen maintains Waystar Holding at Buy, lowers price target to $39 from $42

TD Cowen kept its Buy rating on Waystar Holding but reduced its price target to $39 from $42, citing a 7.1% decrease. The new target suggests a 38.6% upside from the Nov 2 close of $28.14. Recent analyst notes on the company have price targets ranging from $31 to $35.

Original reporting
Published Nov 3, 2026, 4:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 4:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TD Cowen maintains Waystar Holding at Buy, lowers price target to $39 from $42 — source image
Decision brief

The 30-second read

Low
01

Why it matters

A lower price target can influence short-term sentiment and expectations, but without new company-specific disclosures it is less likely to drive a major repricing by itself.

02

Market read

Valuation expectations for WAYR are adjusted downward, but the unchanged Buy rating suggests the Street view remains constructive.

03

What to watch

The article provides no new operational or financial catalyst for Waystar, so the move may reflect model changes rather than a fundamental deterioration.

Relevance 4/10Novelty 4/10Timing: today, as the analyst note/PT cut is newly published

Background

The piece is an analyst note update: TD Cowen maintained a Buy rating on Waystar Holding and reduced its price target.

Market effects

Limited read-through to the broader healthcare IT or media software analyst community, since this is a single-name target adjustment.

No clear regional spillover indicated by the article.

No global macro or cross-market linkage described.

Counterpoint

Because the rating remains Buy, traders may treat the target cut as noise and focus on the implied upside rather than the reduced number.

Key entities

  • Waystar Holding

    Subject of the analyst action, with TD Cowen maintaining Buy and lowering the price target to $39.

  • TD Cowen

    Brokerage issuing the maintained rating and revised price target.

Related articles

$WAYHighAI 8/10

Why is Waystar stock sliding today?

Waystar Holding Corp (WAY) stock fell 4.1% in pre-market trading after Q3 earnings. Revenue rose 21% YoY to $325.6M, and adjusted EPS of $0.44 beat estimates. However, full-year 2026 revenue guidance missed expectations, with a midpoint of $1.282B below the $1.29B consensus. Analysts raised price targets but cited concerns over Q4 growth deceleration.

$WAYHighAI 8/10

Waystar Holding Corp (WAY) Q3 2026 Earnings Call Highlights: Revenue Jumps 21% as AI Bookings Surge

Waystar Holding Corp (WAY) reported Q3 2026 revenue growth of 21% YoY, with adjusted EBITDA up 24% and a 43% margin. Bookings surged 25% YoY, including a major client win. AI innovations drove 43% of Q3 bookings. However, Q4 revenue growth is expected to slow to ~6%, with adjusted EBITDA declining sequentially due to top-line variability and AI investments. Iodine's performance-based pricing model delayed revenue recognition. Net revenue retention was 108%, at the lower end of historical range.

$WAYMed

Waystar: Q3 Earnings Snapshot

Waystar Holding Corp. (WAY) reported Q3 earnings of $31M, or 16 cents per share, beating estimates. Adjusted EPS was 44 cents. Revenue was $325.6M, also exceeding forecasts. The company expects full-year EPS of $1.63-$1.71 and revenue of $1.28B-$1.29B.

$WAYHighAI 8/10

What Waystar (WAY) Said on Its Q3 Earnings Call

Waystar (WAY) reported Q3 bookings for Iodine exceeded year-to-date plans by 74%, with $15M in Q3 bookings. The company launched an autonomous claim-resubmission feature, estimating it could resubmit up to $5B in rejected claims annually. Waystar lowered its full-year revenue forecast to $1.277B-$1.287B but raised adjusted EBITDA guidance to $543M-$549M. The company cited timing pressures for the revenue outlook adjustment.